Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/4283219

Documents

Beta release

Statistics of Safety, efficacy, and biomarker analysis of crizotinib in MET-mutated non-small cell lung cancer-results from the drug rediscovery protocol
Statistics for this year
PeriodVisitsDownloads
202500
Statistics for the last 3 months
PeriodVisitsDownloads
000